Company intelligence / Profile preview

Probac

Sweden

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Probac develops and licenses probiotic strains for functional food applications, particularly in dairy products. The company's strains have demonstrated positive effects on gastrointestinal health and immune system function and are currently used in commercial dairy products.[3]

Therapeutic areas: ImmunologyGastroenterology
Modalities: Live biotherapeutic product therapy
Industry: Non-Drug Biotech

Partnerships

Probi (licensing agreement for probiotic strains in functional food and dairy products globally, excluding Nordic countries)[3]Norrmejerier (dairy company with rights for Nordic market)[3]

Beyond the preview

Go deeper on Probac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probac.

Explore the full profile